# Observational Myelodysplastic Syndromes studies: 50 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 50 trials that are observational for Myelodysplastic Syndromes that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Myelodysplastic Syndromes studies: 50 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/myelodysplastic-syndromes

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 50
- Recruiting or not yet: 50
- Read on: November 19, 2026

## Trials

The 25 newest of 50, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 4, 2026 | NCT07805746 | Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Myelofibrosis, Acute Leukemia, Myelodysplastic Syndrome, Hematopoietic Stem Cell Transplant (HSCT) | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805746) |
| August 21, 2026 | NCT07780552 | CHIP in Health and Disease | VASCage GmbH | Observational | Not yet recruiting | Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780552) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 7, 2026 | NCT07752121 | First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms | Bristol-Myers Squibb | Observational | Recruiting | Myelodysplastic Neoplasms | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752121) |
| July 6, 2026 | NCT07683104 | Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Recruiting | Trisomy 8 Mosaicism, Trisomy 8 Associated Autoinflammatory Disease, Mucosal Ulcerations | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07683104) |
| May 11, 2026 | NCT07578675 | Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS | Institute of Hematology & Blood Diseases Hospital, China | Observational | Recruiting | Aplastic Anemia, Myelodysplastic Syndromes, Autoimmune Hemolytic Anemia, Functional Near-Infrared Spectroscopy | 323 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07578675) |
| May 6, 2026 | NCT07570056 | Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance) | University of Utah | Observational | Not yet recruiting | Myelodysplastic Syndromes, Acute Myeloid Leukemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570056) |
| January 21, 2026 | NCT07355478 | Asia Myelodysplastic Syndrome (MDS) Registry | Bristol-Myers Squibb | Observational | Recruiting | Myelodysplastic Syndromes (MDS) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07355478) |
| November 25, 2025 | NCT07249476 | Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia | Nantes University Hospital | Observational | Not yet recruiting | Leukaemia (Acute Myeloid), Leukaemia (Acute Lymphoblastic), Myelodysplastic Syndrome | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249476) |
| October 3, 2025 | NCT07205523 | High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) | Sponsor not shown (see the record) | Observational | Recruiting | Hematopoietic Stem Cell Transplantation (HSCT), Acute Myeloid Leukemia (AML), Leukemias, Acute Myeloid, Myeloid... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07205523) |
| August 28, 2025 | NCT07145411 | HPC Offered for PRESERVE Expansion | Ossium Health, Inc. | Observational | Recruiting | Bone Marrow Transplant (BMT) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07145411) |
| June 13, 2025 | NCT07019155 | Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants | National Cancer Institute (NCI) | Observational | Recruiting | Germline Mutation, Myelodysplastic Syndromes, Acute Myeloid Leukemia | 510 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07019155) |
| May 31, 2025 | NCT06999954 | Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform | Shwachman-Diamond Syndrome Alliance Inc | Observational | Recruiting | Shwachman-Diamond Syndrome, SDS, IBMF, Congenital Neutropenia, Heme Malignancy, Shwachman Syndrome, Inherited Bone... | 8,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06999954) |
| May 4, 2025 | NCT06956755 | Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia | Groupe Francophone des Myelodysplasies | Observational | Recruiting | Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | 6,990 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956755) |
| January 8, 2025 | NCT06764511 | Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Myelodysplastic Syndromes (MDS) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06764511) |
| November 18, 2024 | NCT06692894 | Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes | University of Vermont | Observational | Recruiting | Myelodysplastic Syndromes, Adult | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06692894) |
| August 23, 2024 | NCT06569095 | Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry | Peking University People's Hospital | Observational | Recruiting | Myelodysplastic Syndromes | 163 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06569095) |
| July 29, 2024 | NCT06524726 | The International PNH Interest Group PNH Registry | International PNH Interest Group | Observational | Recruiting | Paroxysmal Nocturnal Hemoglobinuria | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06524726) |
| July 19, 2024 | NCT06510868 | Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy | University Health Network, Toronto | Observational | Recruiting | Myelodysplastic Syndrome, Acute Myeloid Leukemia | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06510868) |
| June 3, 2024 | NCT06439199 | Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With... | Nantes University Hospital | Observational | Recruiting | Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06439199) |
| April 23, 2024 | NCT06379945 | Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic... | Instituto de Investigación Biomédica de Salamanca | Observational | Recruiting | Myelodysplastic Syndromes | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06379945) |
| February 21, 2024 | NCT06270771 | OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study | Sunnybrook Health Sciences Centre | Observational | Recruiting | MDS, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, RARS-T | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06270771) |
| December 19, 2023 | NCT06175923 | Role of BMP Pathway in MDS Progression | Hospices Civils de Lyon | Observational | Not yet recruiting | Myelodysplastic Syndromes, Acute Myelogenous Leukemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06175923) |
| October 10, 2023 | NCT06073860 | A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia | Bristol-Myers Squibb | Observational | Recruiting | Myelodysplastic Syndrome, Beta Thalassemia | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06073860) |
| August 1, 2023 | NCT05969821 | Clonal Hematopoiesis of Immunological Significance | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Immune System Diseases, Autoimmune Diseases, Inflammation, Autoinflammatory Diseases, Vexas Syndrome, Hematopoiesis... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05969821) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 4 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 3 |
| Peking University People's Hospital | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of Rochester | 2 |
| Dana-Farber Cancer Institute | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Nantes University Hospital | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| University Health Network, Toronto | 2 |
| Hospices Civils de Lyon | 1 |
| International PNH Interest Group | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| St. Jude Children's Research Hospital | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| University of Vermont | 1 |
| Shwachman-Diamond Syndrome Alliance Inc | 1 |
| Institut Paoli-Calmettes | 1 |
| Wake Forest University Health Sciences | 1 |
| Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Ossium Health, Inc. | 1 |
| Cancer Support Community, Research and Training Institute, Philadelphia | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 22 |
| France | 7 |
| China | 6 |
| Canada | 4 |
| South Korea | 2 |
| Germany | 2 |
| Spain | 2 |
| Italy | 2 |
| Singapore | 1 |
| Taiwan | 1 |
| Monaco | 1 |
| Puerto Rico | 1 |
| Czechia | 1 |
| Greece | 1 |
| Israel | 1 |
| Lithuania | 1 |
| Austria | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Afghani restaurants in the United States](https://specstream.ai/data/businesses/afghani-restaurants/united-states)
- [Rail freight companies in the United States](https://specstream.ai/data/businesses/rail-freight-companies/united-states)
- [Junk removal companies in the United States](https://specstream.ai/data/businesses/junk-removal-companies/united-states)
- [Dumpling restaurants in the United States](https://specstream.ai/data/businesses/dumpling-restaurants/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Shoe factory manufacturers in the United States](https://specstream.ai/data/businesses/shoe-factory-manufacturers/united-states)
